Done sou Salè H1B

Akèy › Anplwayè › Janssen Scientific Affairs, LLC

Janssen Scientific Affairs, LLC: Salè H-1B ak pajon

Janssen Scientific Affairs, LLC depoze 17 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 17. Medyèn salè yo ofri a: $190,000.

Demann (LCA)17
Certifye17
Adrès anplwayèNew Brunswick, NJ
Anplwayè H-1B depannNon
Salè medyan ofri$190,000
Mwatye salè yo$182,800–$200,650
10yèm–90yèm pousantaj$168,900–$225,360

Èske Janssen Scientific Affairs, LLC pajone visa H-1B?

Janssen Scientific Affairs, LLC depoze 17 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Jun 9, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.

Demands Green Card (PERM) pou Janssen Scientific Affairs, LLC: 4 →

Salè pa tit travay

Tit travayLCASalè medyan
Associate Director, Real World Value and Evidence - Oncology3$195,000
Manager, Real World Value & Evidence, Oncology2$168,900
Principal Scientific Account Lead2$163,500
Associate Director, Content Strategy and Innovation1$209,200
Director, Real World Value & Evidence, Oncology1$220,000
Associate Director, Real World Value & Evidence, Oncology1$196,200
Integrated Evidence Team Leader, Aticaprant1$233,400
Senior Manager HEOR ( Healthcare Economics & Outcomes)1$173,310
Manager, Search Solutions1$183,600
Associate Director, RWVE Oncology1$182,800
Senior Medical Science Liaison (MSL)1$200,000
Associate Director, Real World Value and Evidence–Hematology1$185,000
Director Real World Value and EOH1$255,200

Aplikasyon pa ane fiskal

Ane fiskalLCASalè medyan
FY20233$209,200
FY20244$179,155
FY20255$183,600
FY20265$195,000

Nivo salè prevanlan

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Kote travay yo ye

Okipasyon

Dènye aplikasyon yo

Tit travaySalè bazKoteSoumètDat kòmansmanEstati
Director Real World Value and EOH$255,200
Nivo IV
Horsham, PAJun 9, 2026Oct 18, 2026Certifye
Associate Director, Real World Value and Evidence–Hematology$185,000
Nivo IV
Horsham, PAApr 14, 2026Apr 20, 2026Certifye
Principal Scientific Account Lead$137,000–$274,000
Nivo IV
Exton, PADec 31, 2025Mar 19, 2026Certifye
Associate Director, Real World Value and Evidence - Oncology$195,000
Nivo III
Livingston, NJNov 5, 2025Nov 18, 2025Certifye
Senior Medical Science Liaison (MSL)$200,000
Nivo IV
Kenmore, WANov 3, 2025Nov 17, 2025Certifye
Associate Director, RWVE Oncology$182,800
Nivo IV
Horsham, PAJul 2, 2025Dec 30, 2025Certifye
Manager, Search Solutions$183,600
Nivo IV
Titusville, NJJun 11, 2025Jun 16, 2025Certifye
Associate Director, Real World Value and Evidence - Oncology$200,650
Nivo IV
Horsham, PAMay 14, 2025Oct 1, 2025Certifye
Principal Scientific Account Lead$190,000
Nivo IV
Titusville, NJMay 14, 2025Sep 19, 2025Certifye
Manager, Real World Value & Evidence, Oncology$168,900
Nivo III
Horsham, PANov 19, 2024Jan 8, 2025Certifye
Associate Director, Real World Value and Evidence - Oncology$185,000
Nivo IV
Horsham, PASep 23, 2024Oct 2, 2024Certifye
Senior Manager HEOR ( Healthcare Economics & Outcomes)$173,310
Nivo III
Titusville, NJMay 14, 2024Nov 5, 2024Certifye
Manager, Real World Value & Evidence, Oncology$168,900
Nivo IV
Horsham, PAApr 4, 2024Oct 1, 2024Certifye
Integrated Evidence Team Leader, Aticaprant$233,400
E-3 · Nivo IV
Titusville, NJDec 28, 2023Apr 2, 2024Certifye
Associate Director, Content Strategy and Innovation$209,200
Nivo IV
Titusville, NJJun 12, 2023Oct 1, 2023Certifye
Director, Real World Value & Evidence, Oncology$220,000
Nivo IV
Horsham, PAMay 10, 2023Oct 18, 2023Certifye
Associate Director, Real World Value & Evidence, Oncology$196,200
Nivo IV
Horsham, PAApr 21, 2023Oct 18, 2023Certifye

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).